200 pharmaceutical companies competed for the third batch of tenders, including more than 50 listed companies.

Pharmaceutical Network Industry Dynamics: The third batch of national collection was officially opened on August 20, and will produce the results of the proposed election on the same day.
the procurement of a total of 56 drug varieties, the number of varieties close to the first two batches of the total, involving malignant tumors, hypertension, diabetes, mental illness and other fields.
Of these 56 varieties, including ammonia bromide, ibuprofen, dichloretamine, dopamine, amino glucose, otine flat, sic acid sidinafi and other well-known varieties, but also non-neonicotinoid, methylcobalamin, teglillo, Moxisa star and other heavy-pound varieties sold annually up to one billion.
it is understood that metformin, Moxisa star, Tigrelo and Capethamin are the four varieties of concern in the industry.
, oral blood glucose-regulating drug metformin in the second batch of harvest regret out, this time in the collection list has attracted much attention in the industry.
At present, there are 27 enterprises of metformin oral regular release dosage form, involving Ling Pharmaceuticals, North China Pharmaceuticals and other enterprises;
industry forecast that in this collection, the production of metformin pharmaceutical companies will face fierce competition, it is expected that metformin price reduction is higher.
, Moxisa star sodium chloride injection in this collection of procurement scale of up to 1,759 million yuan, the bidding of three enterprises.
in addition to the original research enterprise Bayer, Red Sun Pharmaceuticals and Apothecharma are the "barefoot" enterprises of the variety.
faced with large-scale procurement, competitive pattern friendly market opportunities, the industry believes that enterprises will actively campaign.
and whether Bayer will offer the same low price for the variety as the previous sugar-lowering drug, Bayer, is also full of expectations in the industry.
for Grello tablets (90mg) currently rated up to 7 enterprises, including Xinlitai, Zhengda Tianqing, Shi medicine Europe, Yangzijiang and other enterprises.
the global market size of the variety exceeds US$1 billion.
the joint procurement of 1,346 million yuan for Guerrero.
believe the competition will be fierce.
kapetbin currently has sales of 3.49 billion yuan.
joint procurement gave a procurement scale of 1,062 million yuan.
from the collection list, the companies involved in the bidding are Roche and so on.
industry believes that once such large varieties have been the winning bid, enterprises may be able to use this sub-collection to reconstruct the market and price pattern, so the competition between enterprises will also be very fierce.
, about 200 companies participated in the bidding, including more than 50 listed companies.
of which, Yangzijiang Pharmaceuticals, Stone Pharmaceutical Group, Qilu Pharmaceuticals, Shanghai Pharmaceuticals, Hengrui Pharmaceuticals, Colum Pharmaceuticals, etc. are the collection involving more varieties of enterprises, but also domestic generic head enterprises.
Of these, from the list of the higher market share of the stock varieties of the enterprises collated, Hengrui's Carpettamine tablets, lactocline tablets, non-busta tablets and hydrochloric acid ammonia bromine tablets, the market share of the four over-rated varieties is higher, and the market share of sales in 2020Q1 reached 11. 4%, 30.0%, 41.9% and 12.1%, with sample hospital sales reaching 1,240 million yuan, 728 million yuan, 522 million yuan and 18.957 million yuan, respectively, in 2019.
well-known, the purpose of carrying out volume procurement is to extrude the water of inflated drug prices and realize imitation to replace the original research.
can be expected that, with the arrival of the results of the collection, for the original sales of higher market share of varieties, once the winning bid, the market share of the relevant enterprises will further expand, conducive to accelerating the realization of generic substitution.
and for some of the original low market share of the varieties, after winning the bid, the relevant "barefoot enterprises" can also improve profitability and improve cash flow.
.